It has been a fantastic last three years of my research career @CentenaryInst. I am really grateful to my mentors @Peter@JessTiffen, labmates and all other colleagues.
I am really excited and looking forward to the next phase of my research career @FisherLabMGH@harvardmed
Delighted to share our latest work which I co-lead with @JessTiffen. Epigenetic inhibitor against BET proteins and antiCTLA-4 synergistically reduce tumor growth which are resistance to anti-PD1. Hope it can make a meaningful impact in clinical settings. @DrHYTseng@JessTiffen.
More great work from my team on epigenetic BET inhibitors.
Here we show they combine well with antiCTLA-4 immune checkpoint inhibition (ICI) to combat melanoma with innate resistance to antiPD-1/L1 (frontline) ICI in a mouse model.
@DrHYTseng@emran_geb
https://t.co/FhEvXXg3Gz
Great piece of work from my PhD Lab .
Yet another strong evidence of epigenetic reprogramming in adaptive resistance of multiple solid tumor models. Congrats to everyone involved in this fascinating project. Happy to be a part of it. @HelmutSchaider@DinoopMenon @Heinz@HaassLab
Hot off the press:
Drug Resist Updat, accepted 4th August 2023;
doi: https://t.co/epapwck2qb
Congrats to Helmut and his team and collaborators - fantastic work!
#FrazerInstUQ, @UQDRC, @UQMedicine, @TRI_info, @CUDenver, @UCSF, @otago, @JOAN_RESEARCH, @TheWistar,
@karim_marwah It depends on whether you want a challenging yet exciting career but immensely unstable versus a job that is more reliable and has an excellent work-life balance. At the end of the day happiness matters, and your mental peace matters. Good luck
The Best Scientists 🧵
I have heard a lot about the Best Scientists 🧑🔬
Maybe the best scientists...
make impactful discoveries,
publish in gilded journals,
garner millions in funding,
with lots of indirects.
And prizes, all the prizes🏆
And everybody respects them.
OR…
Happy to share our latest commentary article on
"Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma" based on a recent seminal work and our previous works. First from @FisherLabMGH#Epigenetics#Melanoma
https://t.co/6WQsgIdyiD
Prof Peter Hersey is generally recognised as a pioneer of the #melanoma treatment – #immunotherapy – in Australia. Having first started treating melanoma patients in 1980, he has seen great advances in field but he is not going to stop there.
More 👉 https://t.co/9muODpKaKZ
"MFN2 Stabilization: A Bridge for Endoplasmic Reticulum Stress Sensitivity in Melanoma," a commentary by Charles Adelmann, Inbal Rachmin, & David Fisher
https://t.co/m8YQoYEL9U #JIDJournal#dermscience
Congratulations Australia for winning the maiden T20 World cup title. What a team! What a match! Super proud of you guys...
Love and respect for New Zealand. Well played. In the end, cricket wins.
#T20WorldCupFinal
https://t.co/O7T7hMto6X